References
- Haerle SK, Gullane PJ, Witterick IJ, Zweifel C, Gentili F. Sinonasal carcinomas: epidemiology, pathology, and management. Neurosurg Clin N Am 2013;24:39-49. https://doi.org/10.1016/j.nec.2012.08.004
- Homma A, Oridate N, Suzuki F, et al. Superselective highdose cisplatin infusion with concomitant radiotherapy in patients with advanced cancer of the nasal cavity and paranasal sinuses: a single institution experience. Cancer 2009;115:4705-14. https://doi.org/10.1002/cncr.24515
- Hoppe BS, Stegman LD, Zelefsky MJ, et al. Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting: the MSKCC experience. Int J Radiat Oncol Biol Phys 2007;67:691-702. https://doi.org/10.1016/j.ijrobp.2006.09.023
- Blanch JL, Ruiz AM, Alos L, Traserra-Coderch J, Bernal-Sprekelsen M. Treatment of 125 sinonasal tumors: prognostic factors, outcome, and follow-up. Otolaryngol Head Neck Surg 2004;131:973-6. https://doi.org/10.1016/j.otohns.2004.08.001
- Khademi B, Moradi A, Hoseini S, Mohammadianpanah M. Malignant neoplasms of the sinonasal tract: report of 71 patients and literature review and analysis. Oral Maxillofac Surg 2009;13:191-9. https://doi.org/10.1007/s10006-009-0170-8
- Suarez C, Llorente JL, Fernandez De Leon R, Maseda E, Lopez A. Prognostic factors in sinonasal tumors involving the anterior skull base. Head Neck 2004;26:136-44. https://doi.org/10.1002/hed.10358
- Carrau RL, Segas J, Nuss DW, et al. Squamous cell carcinoma of the sinonasal tract invading the orbit. Laryngoscope 1999;109(2 Pt 1):230-5. https://doi.org/10.1097/00005537-199902000-00012
- Imola MJ, Schramm VL Jr. Orbital preservation in surgical management of sinonasal malignancy. Laryngoscope 2002;112(8 Pt 1):1357-65. https://doi.org/10.1097/00005537-200208000-00007
- Kovacs AF, Eberlein K, Hulsmann T. Organ preservation treatment using TPF: a pilot study in patients with advanced primary and recurrent cancer of the oral cavity and the maxillary sinus. Oral Maxillofac Surg 2009;13:87-93. https://doi.org/10.1007/s10006-009-0159-3
- Larson DL, Christ JE, Jesse RH. Preservation of the orbital contents in cancer of the maxillary sinus. Arch Otolaryngol 1982;108:370-2. https://doi.org/10.1001/archotol.1982.00790540042011
- Nishino H, Ichimura K, Tanaka H, et al. Results of orbital preservation for advanced malignant maxillary sinus tumors. Laryngoscope 2003;113:1064-9. https://doi.org/10.1097/00005537-200306000-00028
- Reyes C, Mason E, Solares CA, Bush C, Carrau R. To preserve or not to preserve the orbit in paranasal sinus neoplasms: a meta-analysis. J Neurol Surg B Skull Base 2015;76:122-8.
- Sakashita T, Hayashi R, Homma A, et al. Multi-institutional retrospective study for the evaluation of ocular functionpreservation rates in maxillary sinus squamous cell carcinomas with orbital invasion. Head Neck 2015;37:537-42. https://doi.org/10.1002/hed.23639
- Papadimitrakopoulou VA, Ginsberg LE, Garden AS, et al. Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinoma. Cancer 2003;98:2214-23. https://doi.org/10.1002/cncr.11771
- Rajapurkar M, Thankappan K, Sampathirao LM, Kuriakose MA, Iyer S. Oncologic and functional outcome of the preserved eye in malignant sinonasal tumors. Head Neck 2013;35:1379-84.
- Marcial VA. Ninth annual del Regato lecture: optimal multidisciplinary management of head and neck cancer. Int J Radiat Oncol Biol Phys 1987;13:393-401. https://doi.org/10.1016/0360-3016(87)90014-9
- Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228-47. https://doi.org/10.1016/j.ejca.2008.10.026
- Kreppel M, Danscheid S, Scheer M, et al. Neoadjuvant chemoradiation in squamous cell carcinoma of the maxillary sinus: a 26-year experience. Chemother Res Pract 2012;2012:413589.
- Kim JH, Lee YS, Chung YS, et al. Treatment outcomes of concurrent chemoradiotherapy for locally advanced sinonasal squamous cell carcinoma: a single-institution study. Acta Otolaryngol 2015;135:1189-95. https://doi.org/10.3109/00016489.2015.1061697
- Al-Mamgani A, van Rooij P, Mehilal R, Tans L, Levendag PC. Combined-modality treatment improved outcome in sinonasal undifferentiated carcinoma: single-institutional experience of 21 patients and review of the literature. Eur Arch Otorhinolaryngol 2013;270:293-9. https://doi.org/10.1007/s00405-012-2008-5
- Kang JH, Cho SH, Kim JP, et al. Treatment outcomes between concurrent chemoradiotherapy and combination of surgery, radiotherapy, and/or chemotherapy in stage III and IV maxillary sinus cancer: multi-institutional retrospective analysis. J Oral Maxillofac Surg 2012;70:1717-23. https://doi.org/10.1016/j.joms.2011.06.221
- Duthoy W, Boterberg T, Claus F, et al. Postoperative intensitymodulated radiotherapy in sinonasal carcinoma: clinical results in 39 patients. Cancer 2005;104:71-82. https://doi.org/10.1002/cncr.21100
Cited by
- Sinonasal Squamous Cell Carcinoma, a Narrative Reappraisal of the Current Evidence vol.13, pp.11, 2016, https://doi.org/10.3390/cancers13112835
- Orbital exenteration and reconstruction in a tertiary UK institution: a 5-year experience vol.40, pp.4, 2016, https://doi.org/10.1080/01676830.2020.1775262
- Surgical Management of Sinonasal Cancers: A Comprehensive Review vol.13, pp.16, 2016, https://doi.org/10.3390/cancers13163995